David John Williams Date of appointment 28 April 2026 Part 1 - Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

À propos de David John Williams Date of appointment 28 April 2026 Part 1 - Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

David John Williams est Administrateur chez Arovella Therapeutics Limited. Dans ce rôle, il participe à la gouvernance de l'entreprise et à la prise de décisions stratégiques. Son expérience et ses compétences sont précieuses pour le développement et la croissance d'Arovella.